BofA cuts Ionis Pharmaceuticals stock price target on lower sales outlook

🌐 Investing.com (Cyprus) —
BofA cuts Ionis Pharmaceuticals stock price target on lower sales outlook

AI Summary

Bank of America lowered its price target for Ionis Pharmaceuticals, citing a weaker sales outlook. The headline does not specify the revised target or the products behind the forecast change.

Markets Health Ionis Pharmaceuticals Bank of America price target sales outlook pharmaceuticals stock analysis

Read original source →